Lofarma S.p.a.

Consiglio Nazionale Delle Ricerche

Stefania Zanotta

Giovanni Mistrello

Daniela Roncarolo

Paolo Falagiani

Monica Sturaro

Angelo Viotti

Dario Zanoni

A method of making and a modified allergen having reduced allergenicity and preserved immunogenicity compared to corresponding native allergenic material. The preserved immunogenicity is elicited by a IgG-mediated antibody response, all or part of the primary amine groups of the lysine residues of the native allergenic material are functionalized with carbamoyl or thiocarbamoyl moieties, and all or part of the primary amine groups of the arginine residues of the carbamoyl- or thiocarbamoyl functionalized allergenic material are further functionalized with dialdehyde or diketal moieties. The raw allergenic material is selected from the group consisting of DP mites extract, Der p1, ovalbumin and Lipid Transfer Protein (LTP), the average percentage of modified primary amine groups of the lysine ranges between 75% and 100%; and the average percentage of the substituted arginine residues ranges between 25% and 10%.

Allergoids derived from allergenes

Disclosed are hypoallergenic variants of Mal d 1, the major allergen from, and the uses thereof in the treatment of allergic diseases.

Hypoallergenic variants of mal d 1, the major allergen from malus domestica

Disclosed are hypoallergenic variants of Phl p 5, the major allergen from, and the uses thereof in the treatment of allergic diseases.

[object Object]

The invention provides hypoallergenic variants of Bet v 1 major allergen fromplant pollen and the use thereof for the preventive or therapeutic treatment of allergic diseases.

The invention provides hypoallergenic variants of Bet v 2 major allergen fromplant pollen and the use thereof for the preventive or therapeutic treatment of allergic diseases.

Hypoallergenic variants of the major allergen Ph1 p 1 ofplants and their use in the therapy of the allergic diseases is disclosed.

Variants of Phleum pratense allergenic proteins

Variants of allergens of species with reduced allergenic activity.

Growing community of inventors

Milan, Italy

Stefania Zanotta